Patent Assignment
Reel/Frame 021145/0905
Correct Erroneous Application Number at Reel/Frame Nos. 021132/0254. Correct Application Number Is 11/914,104
Recorded: 2008-06-24
Pages: 9
Assignors
DEFREES, SHAWN
Executed: 2007-11-27
BAYER, ROBERT J.
Executed: 2007-11-15
ZOPF, DAVID A.
Executed: 2007-11-27
KANG, JICHAO
Executed: 2007-11-16
WILLETT, WALTER SCOTT
Executed: 2007-12-10
Assignee
NEOSE TECHNOLOGIES, INC.
102 ROCK ROAD, HORSHAM, PENNSYLVANIA, 19044
Covered Property
(1)
Glycopegylated Erythropoietin Formulations
Application:
11/914,104 →
Publication:
US 2011/0003744
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 20, 2008
From: DEFREES, SHAWN; BAYER, ROBERT J.; ZOPF, DAVID A.; KANG, JICHAO
To: NEOSE TECHNOLOGIES, INC.
Reel/Frame 021132/0254 →
Assignment of Assignor's Interest
Feb 23, 2009
From: NEOSE TECHNOLOGIES, INC.
To: NOVO NORDISK A/S
Reel/Frame 022441/0937 →
Corrective Assignment to Correct the Please Change the Assignee from Biogenerix Ag to Novo Nordisk a/S. Previously Recorded on Reel 022404 Frame 0634. Assignor(S) Hereby Confirms the Assignor(S) Hereby Confirms the Correct Assignee Is Novo Nordisk a/S, Novo Alle, 2880 Bagsvaerd, Denmark.
Apr 9, 2009
From: BIOGENERIX AG
To: NOVO NORDISK A/S
Reel/Frame 022527/0614 →